Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating the efficacy and safety of AND017 in dialysis-dependent chronic kidney disease patients with anemia; recruitment is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AND017

Snippet

Sponsor: Kind Pharmaceuticals LLC | Conditions: Anemia Due to Chronic Kidney Disease | Phase 3 | Status: RECRUITING